LitAlert ~~ GeneLit.com

    • Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series.
    • Kasherman L, Garg S, Tchrakian N, Clarke B, Karakasis K, Kim RH, Stockley TL, Dhani N, Oza AM, Lheureux S.
    • Gynecol Oncol Rep. 2021 Feb 12;36:100729. doi: 10.1016/j.gore.2021.100729. eCollection 2021 May.
    • The results of multigene panel sequencing in Slovak HBOC families.
    • Konecny M, Kosova K, Tilandyova P, Wachsmannova L, Baldovic M, Krajcovic J, Patlevicova A, Markus J, Ciernikova S.
    • Neoplasma. 2021 Mar 17:201204N1307. doi: 10.4149/neo_2021_201204N1307. Epub ahead of print.
    • Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know.
    • Della Corte L, Foreste V, Di Filippo C, Giampaolino P, Bifulco G.
    • Expert Opin Investig Drugs. 2021 Mar 16. doi: 10.1080/13543784.2021.1901882. Epub ahead of print.
    • Review
    • Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
    • Ben Ayed-Guerfali D, Ben Kridis-Rejab W, Ammous-Boukhris N, Ayadi W, Charfi S, Khanfir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.
    • J Transl Med. 2021 Mar 16;19(1):108. doi: 10.1186/s12967-021-02772-y.
    • Evaluation of online Spanish and English health materials for preventive mastectomy. are we providing adequate information?
    • Del Valle DD, Pardo JA, Maselli AM, Valero MG, Fan B, Seyidova N, James TA, Lee BT.
    • Breast Cancer Res Treat. 2021 Mar 15. doi: 10.1007/s10549-021-06171-1. Epub ahead of print.
    • Review
    • Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
    • Everett JN, Burgos G, Chun J, Baptiste A, Khanna LG, Oberstein PE, Simeone DM.
    • Cancer. 2021 Mar 15. doi: 10.1002/cncr.33500. Epub ahead of print.
    • Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre.
    • Beard C, Monohan K, Cicciarelli L, James PA.
    • Eur J Hum Genet. 2021 Mar 15. doi: 10.1038/s41431-021-00848-3. Epub ahead of print.
    • An updated review of epidemiology, risk factors, and management of male breast cancer.
    • Khan NAJ, Tirona M.
    • Med Oncol. 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x.
    • Review
    • Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand.
    • Patel PS, Algouneh A, Hakem R.
    • Oncogene. 2021 Mar 14. doi: 10.1038/s41388-021-01744-2. Epub ahead of print.
    • Review
    • Characterization of genetic counselor practices in inpatient care settings.
    • Magness E, Magoulas P, Moscarello T, Ma D, Helm BM, Mizerik E.
    • J Genet Couns. 2021 Mar 13. doi: 10.1002/jgc4.1401. Epub ahead of print.
    • Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers.
    • Depypere H, Su Y, Dang N, Poppe B, Stanczyk F, Janssens J, Russo J.
    • Eur J Cancer Prev. 2021 Mar 12. doi: 10.1097/CEJ.0000000000000664. Epub ahead of print.
    • Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?
    • Kwon DH, Booth CM, Prasad V.
    • Eur Urol. 2021 Mar 12:S0302-2838(21)00168-8. doi: 10.1016/j.eururo.2021.02.041. Epub ahead of print.
    • Editorial
    • Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors.
    • See JE, Shin HR, Jang G, Kweon J, Kim Y.
    • J Vis Exp. 2021 Feb 28;(168). doi: 10.3791/61557.
    • Video